Re-expression of LINC01355 suppresses the growth and tumorigenesis of breast cancer cells, which involves the stabilization of FOXO3 and enhancement of FOXO3-mediated transrepression of CCND1. This evidence concerns the gene FOXO3 and breast carcinoma.